A Risk-Benefit Assessment of Pharmacotherapies for Clinical Depression in Children and Adolescents
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 20 (1) , 59-75
- https://doi.org/10.2165/00002018-199920010-00006
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- A component analysis of cognitive-behavioral treatment for depression.Journal of Consulting and Clinical Psychology, 1996
- Maintenance Therapies for Late-LifeInternational Psychogeriatrics, 1995
- Psychosocial risk factors for future adolescent suicide attempts.Journal of Consulting and Clinical Psychology, 1994
- A Double-Blind Comparison of Paroxetine With Imipramine in the Long-Term Treatment of DepressionJournal of Clinical Psychopharmacology, 1993
- Long-Term Treatment of Major Depressive Disorder With ParoxetineJournal of Clinical Psychopharmacology, 1993
- Prevalence of Childhood Depression: Results of the First Study in SpainJournal of Child Psychology and Psychiatry, 1993
- Response of psychotic depression subtypes to pharmacotherapyJournal of Affective Disorders, 1993
- Clinical aspects of developmental pharmacology and toxicologyPharmacology & Therapeutics, 1983
- Variations in the Pattern of Pubertal Changes in BoysArchives of Disease in Childhood, 1970
- Variations in pattern of pubertal changes in girls.Archives of Disease in Childhood, 1969